awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44115102-9A0EBFE7-4C8D-45D5-A80B-F27D8FF9EAC2
Q44115102-9A0EBFE7-4C8D-45D5-A80B-F27D8FF9EAC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44115102-9A0EBFE7-4C8D-45D5-A80B-F27D8FF9EAC2
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.
P577
Q44115102-9A0EBFE7-4C8D-45D5-A80B-F27D8FF9EAC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44115102-9A0EBFE7-4C8D-45D5-A80B-F27D8FF9EAC2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7d56d8bfe747f676737349f95a577b4a4799c2b
P577
2002-08-01T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
59be904d70afec6cf9f593e614d9a11e